Recombinant PDCD1 (Cetrelimab Biosimilar) antibody
The Human Monoclonal anti-PDCD1 (Cetrelimab Biosimilar) antibody is suitable to detect PDCD1 (Cetrelimab Biosimilar) in samples from Human. It has been validated for ELISA, BLI, FACS, Func and SPR.
Catalog No. ABIN7676069
-15% Promotion 2026
$294.23
save $51.92 (-15 %)
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 11 Business Days
Quick Overview for Recombinant PDCD1 (Cetrelimab Biosimilar) antibody (ABIN7676069)
Target
PDCD1 (Cetrelimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This PDCD1 (Cetrelimab Biosimilar) antibody is un-conjugated
Application
ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-PDCD1 / PD-1 / CD279 Reference Antibody (cetrelimab)
-
Characteristics
- Anti-PDCD1 / PD-1 / CD279 Reference Antibody (cetrelimab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG4 S228P
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- PDCD1 (Cetrelimab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- Q15116
Target
-
You are here:
